These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9314141)

  • 1. Atherosclerosis of the liver allograft.
    McCaughan GW; Bishop GA
    J Hepatol; 1997 Sep; 27(3):592-8. PubMed ID: 9314141
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems and significance of liver allograft as an immunologically privileged organ].
    Chen ZH
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):221. PubMed ID: 15760561
    [No Abstract]   [Full Text] [Related]  

  • 3. An experimental model of rat liver allograft rejection monitored with FNAB.
    Martelius T; Mäkisalo H; Höckerstedt K; Taskinen E; Lautenschlager I
    Transplant Proc; 1995 Dec; 27(6):3550-1. PubMed ID: 8540097
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible role of hepatic nonparenchymal cells in liver allograft rejection.
    Saito S; Sakagami K; Fujiwara T; Higaki K; Matsuno T; Orita K
    Transplant Proc; 1993 Apr; 25(2):1957-8. PubMed ID: 8470242
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunology of acute and chronic hepatic allograft rejection.
    Vierling JM
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S1-S20. PubMed ID: 10431013
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic mechanisms of hepatic allograft rejection.
    Vierling JM
    Semin Liver Dis; 1992 Feb; 12(1):16-27. PubMed ID: 1570548
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody-mediated rejection of renal allograft in combined liver-kidney transplant.
    Barth RN; Campos L; Kukuruga DL; Drachenberg C; Philosophe B
    Clin Transplant; 2010; 24(5):685-90. PubMed ID: 19925465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of hepatic allograft rejection.
    Kamada N
    Semin Liver Dis; 1992 Feb; 12(1):1-15. PubMed ID: 1570547
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonspecific repeated skin graft sensitization induces liver allograft rejection in a spontaneously tolerant liver allograft model.
    Tanigawa T; Dahmen U; Dirsch O; Doebel L; Rogiers X; Lindkaer-Jensen S; Broelsch CE
    Transplant Proc; 1997; 29(1-2):1047-9. PubMed ID: 9123191
    [No Abstract]   [Full Text] [Related]  

  • 10. Indirect T-cell recognition in human allograft rejection.
    Suciu-Foca N; Liu Z; Colovai AI; Fisher P; Ho E; Reed EF; Rose EA; Michler RE; Hardy MA; Cocciolo P; Gargano F; Cortesini R
    Transplant Proc; 1997; 29(1-2 /01):1012-3. PubMed ID: 9123174
    [No Abstract]   [Full Text] [Related]  

  • 11. Levels of cytokine expression in rat liver allograft rejection compared to allograft tolerance.
    Sun J; Matsumoto Y; McCaughan GW; Gallagher ND; Sheil AG; Bishop GA
    Transplant Proc; 1992 Oct; 24(5):2309. PubMed ID: 1413072
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific inhibition of heart allograft rejection by serum from liver-grafted rats.
    Kamada N; Shinomiya T; Tamaki T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):570-1. PubMed ID: 3274823
    [No Abstract]   [Full Text] [Related]  

  • 13. Kupffer cell expression of CD40L (CD154) in human chronic liver allograft rejection.
    Gaweco AS; Wiesner RH; Yong S; Krom R; Porayko M; Chejfec G; McClatchey KD; Van Thiel DH
    Transplant Proc; 1999; 31(1-2):560-1. PubMed ID: 10083237
    [No Abstract]   [Full Text] [Related]  

  • 14. Intragraft eosinophilia and interleukin-5 mRNA accompany liver allograft rejection.
    Martinez OM; Krams SM; Villanueva JC; Ferrell L; Lake J; Roberts JP; Ascher NL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):126-7. PubMed ID: 8438249
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of liver allograft rejection: indirect allorecognition.
    Renna-Molajoni E; Cinti P; Elia L; Orlandini AM; Cocciolo P; Molajoni J; Ho E; Suciu-Foca N; Cortesini R
    Transplant Proc; 1999; 31(1-2):409-10. PubMed ID: 10083165
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic liver allograft dysfunction.
    Desai M; Neuberger J
    Transplant Proc; 2009 Mar; 41(2):773-6. PubMed ID: 19328977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic allograft arteriosclerosis: contributing factors and molecular mechanisms in the light of experimental studies.
    Räisänen-Sokolowski A; Häyry P
    Transpl Immunol; 1996 Jun; 4(2):91-8. PubMed ID: 8843584
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence that liver grafting suppresses allograft rejection and controls graft-vs-host reaction.
    Kobayashi E; Kamada N; Enosawa S; Delriviere L; Toyama N; Miyata M
    Transplant Proc; 1993 Feb; 25(1 Pt 2):872-3. PubMed ID: 8442251
    [No Abstract]   [Full Text] [Related]  

  • 19. Establishment of a chronic rejection model for orthotopic liver transplantation in the rat.
    Wu YB; Huang QM; Liu JF
    Eur Surg Res; 2011; 46(2):94-101. PubMed ID: 21228596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients.
    Jindal RM; Popescu I; Schwartz ME; Emre S; Boccagni P; Miller CM
    Transplantation; 1994 Aug; 58(3):370-2. PubMed ID: 7519799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.